Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 20.53M 19.17M 17.6M 33.18M 2.25B 33.76M 226M 88.52M 1.12B 88.74M 86.77M 3.7B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 36.66M 34.23M 31.42M 59.25M 4.02B 60.28M 404M 158M 2.01B 158M 155M 6.61B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
04/08/17 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
15/05/17 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/02/17 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/11/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/10/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/05/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/02/16 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/02/16 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/12/15 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/12/15 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/12/15 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/11/15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/10/15 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 month-14.63%
3 months-32.69%
6 months-33.96%
Current year+6.06%
1 month 0
Extreme 0.0035
0
Current year 0
Extreme 0.0016
0.01
1 year 0
Extreme 0.0016
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 0
0.02
10 years 0
Extreme 0
0.73
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-46.97%+66.67% 1.33M
+1.68%+7.42%+34.10%+469.11% 2.28B
-0.47%+16.02%-30.00%-53.54% 1.92B
-0.18%+1.68% - - 1.85B
+2.16%+3.50%+93.29%+504.58% 1.37B
-4.03%-1.35%-46.92%+33.33% 1.3B
-0.75%-1.99%+329.72%+914.28% 1.1B
-2.19%+0.47%+56.84%+43.47% 1.01B
+3.33%+22.39%+23.83%+69.34% 916M
+9.99%+60.96%+49.54%-30.24% 577M
Average +0.94%+9.37%+51.49%+224.11% 1.23B
Weighted average by Cap. +0.48%+7.69%+53.37%+267.30%

Financials

2015 2016
Net sales 25.48M 22.15M 20.68M 18.98M 35.79M 2.43B 36.41M 244M 95.48M 1.21B 95.71M 93.59M 3.99B 32.33M 28.1M 26.23M 24.08M 45.41M 3.08B 46.2M 309M 121M 1.54B 121M 119M 5.07B
Net income 5.49M 4.78M 4.46M 4.09M 7.72M 524M 7.85M 52.57M 20.59M 261M 20.64M 20.18M 861M 2.06M 1.79M 1.67M 1.54M 2.9M 196M 2.95M 19.72M 7.72M 97.98M 7.74M 7.57M 323M
Net Debt 24.8M 21.56M 20.13M 18.48M 34.84M 2.36B 35.45M 237M 92.94M 1.18B 93.17M 91.11M 3.89B 18.56M 16.13M 15.06M 13.82M 26.07M 1.77B 26.52M 178M 69.55M 882M 69.71M 68.17M 2.91B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. AOXG Stock